BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND STAT6, D12S1644, 6778, ENSG00000166888, IL-4-STAT, P42226, STAT6B, STAT6C AND Treatment
18 results:

  • 1. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
    Salaverria I; Weigert O; Quintanilla-Martinez L
    Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
    Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
    Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.
    Wagner A; Rouleau M; Villeneuve L; Le T; Peltier C; Allain ÉP; Beaudoin C; Tremblay S; Courtier F; Nguyen Van Long F; Laverdière I; Lévesque É; Banerji V; Vanura K; Guillemette C
    Cells; 2023 May; 12(9):. PubMed ID: 37174695
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Traditional Chinese medicine compound, Bu Sheng Hui Yang Fang, promotes the proliferation of lymphocytes in the immunosuppressed mice potentially by upregulating IL-4 signaling.
    Wang Y; Tan J; Hu P; Pei Q; Wen Y; Ma W; Shi K; Li Z; Li H; Cheng F; Gu X; Yao X; Man Y; Zhao R; Feng S; Ding X; Yang T
    Biomed Pharmacother; 2021 Feb; 134():111107. PubMed ID: 33341059
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia.
    Forthun RB; Hellesøy M; Sulen A; Kopperud RK; Sjøholt G; Bruserud Ø; McCormack E; Gjertsen BT
    J Cancer Res Clin Oncol; 2019 Jul; 145(7):1729-1749. PubMed ID: 31111215
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
    Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia.
    Fiorcari S; Maffei R; Audrito V; Martinelli S; Ten Hacken E; Zucchini P; Grisendi G; Potenza L; Luppi M; Burger JA; Deaglio S; Marasca R
    Oncotarget; 2016 Oct; 7(40):65968-65981. PubMed ID: 27602755
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia.
    Toniolo PA; Liu S; Yeh JE; Ye DQ; Barbuto JA; Frank DA
    Oncotarget; 2016 Jul; 7(29):46301-46314. PubMed ID: 27317770
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. IL-4 enhances expression and function of surface IgM in CLL cells.
    Aguilar-Hernandez MM; Blunt MD; Dobson R; Yeomans A; Thirdborough S; Larrayoz M; Smith LD; Linley A; Strefford JC; Davies A; Johnson PM; Savelyeva N; Cragg MS; Forconi F; Packham G; Stevenson FK; Steele AJ
    Blood; 2016 Jun; 127(24):3015-25. PubMed ID: 27002119
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
    Han SS; Han S; Kamberos NL
    Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Interleukin-4 and interleukin-13 inhibit the expression of leukemia inhibitory factor and interleukin-11 in fibroblasts.
    Souza PP; Palmqvist P; Lundberg P; Lundgren I; Hänström L; Souza JA; Conaway HH; Lerner UH
    Mol Immunol; 2012 Jan; 49(4):601-10. PubMed ID: 22142941
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Membrane-bound IL-15 stimulation on peripheral blood natural kiler progenitors leads to the generation of an adherent subset co-expressing dendritic cells and natural kiler functional markers.
    Negrini S; Giuliani M; Durali D; Chouaib S; Azzarone B
    Haematologica; 2011 May; 96(5):762-6. PubMed ID: 21242188
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. IL-13 upregulates GPIIb expression in megakaryocytic cell lines via stat6.
    Shi X; Cai W; Zhou Y; Zhang X; Xiong L; Li R; Yu X; Li W
    Anat Rec (Hoboken); 2010 Sep; 293(9):1470-6. PubMed ID: 20652946
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. stat6 activation by Toxoplasma gondii infection induces the expression of Th2 C-C chemokine ligands and B clade serine protease inhibitors in macrophage.
    Ahn HJ; Kim JY; Ryu KJ; Nam HW
    Parasitol Res; 2009 Oct; 105(5):1445-53. PubMed ID: 19655172
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Photodynamic treatment (ALA-PDT) suppresses the expression of the oncogenic Bcr-Abl kinase and affects the cytoskeleton organization in K562 cells.
    Pluskalová M; Peslová G; Grebenová D; Halada P; Hrkal Z
    J Photochem Photobiol B; 2006 Jun; 83(3):205-12. PubMed ID: 16495075
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via stat6 and preserves graft-versus-leukemia effects.
    Reddy P; Teshima T; Hildebrandt G; Williams DL; Liu C; Cooke KR; Ferrara JL
    Blood; 2003 Apr; 101(7):2877-85. PubMed ID: 12433681
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. HTLV-1 cell lines differ in constitutively activated signaling pathways that can be altered by cytokine exposure.
    Liang W; Hague B; Zhao T; Kindt TJ
    Virology; 2001 Nov; 290(1):91-8. PubMed ID: 11883009
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.